Results 71 to 80 of about 208,651 (377)

Incidence of inguinal hernia after radical prostatectomy: a systematic review and meta-analysis.

open access: yesJournal of Urology, 2020
PURPOSE To investigate the incidence of inguinal hernia following radical prostatectomy, we compared the incidence of inguinal hernia after open retropubic radical prostatectomy with the laparoscopic and robot-assisted radical prostatectomies, and with ...
R. Alder, D. Zetner, J. Rosenberg
semanticscholar   +1 more source

Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Prostate cancer is a significant health and economic concern in Germany. In particular, screening methods require greater optimisation to prevent overdiagnosis and unnecessary procedures and to ensure clinical benefit. Here, prostate cancer screening strategies were evaluated to determine which are most effective in terms of cost and health
Muchandifunga Trust Muchadeyi   +10 more
wiley   +1 more source

Association between PSA values and surveillance quality after prostate cancer surgery

open access: yesCancer Medicine, 2019
Background Although prostate‐specific antigen (PSA) testing is used for prostate cancer detection and posttreatment surveillance, thresholds in these settings differ.
Christina Hunter Chapman   +13 more
doaj   +1 more source

Pathologic outcomes during the learning curve for robotic-assisted laparoscopic radical prostatectomy

open access: yesInternational Brazilian Journal of Urology, 2008
OBJECTIVE: We report our initial experience with 62 patients undergoing robotic-assisted laparoscopic prostatectomy (RALP), focusing on the primary parameter of positive surgical margins.
Amul Shah   +5 more
doaj   +1 more source

Clinical impact of real‐time androgen receptor alteration monitoring on metastatic castration‐resistant prostate cancer treatment in real‐world settings

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Androgen receptor (AR) alterations contribute to treatment resistance against androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer. This real‐world study demonstrates that AR monitoring via liquid biopsy predicts treatment response and progression in metastatic castration‐resistant prostate cancer.
Regina Stitz   +7 more
wiley   +1 more source

Is rhabdomyolysis an anaesthetic complication in patients undergoing robot-assisted radical prostatectomy?

open access: yesJournal of Minimal Access Surgery, 2017
Background: In patients undergoing robot-assisted radical prostatectomy (RARP), pneumoperitoneum, intraoperative fluid restriction and prolonged Trendelenburg position may cause rhabdomyolysis (RM) due to hypoperfusion in gluteal muscles and lower ...
Gulsah Karaoren   +3 more
doaj   +1 more source

Improved early and late continence following robot‐assisted radical prostatectomy with concurrent bladder neck fascial sling (RoboSling)

open access: yesBJUI Compass, 2023
Objective To describe a novel RoboSling technique performed at the time of robot‐assisted radical prostatectomy (RARP) and its utility for enhancing urinary function recovery postoperatively.
Scott Leslie   +14 more
doaj   +1 more source

Using Explainable Machine Learning to Explore the Impact of Synoptic Reporting on Prostate Cancer

open access: yesAlgorithms, 2022
Machine learning (ML) models have proven to be an attractive alternative to traditional statistical methods in oncology. However, they are often regarded as black boxes, hindering their adoption for answering real-life clinical questions.
Femke M. Janssen   +5 more
doaj   +1 more source

TMB‐High, MSI‐High Castration‐Resistant Prostate Cancer Treated With Pembrolizumab

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction The use of pembrolizumab in patients with microsatellite instability‐high (MSI‐high) and tumor mutation burden‐high (TMB‐high) prostate cancer in Japan is not widely reported. Here, we report the case of a patient with MSI‐high and TMB‐high prostate cancer who responded well to pembrolizumab after multiple systemic treatments ...
Satoshi Muraoka   +8 more
wiley   +1 more source

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT

open access: yesHealth Technology Assessment, 2018
Background: Prostate cancer (PCa) is the most common cancer in men in the UK. Patients with intermediate-risk, clinically localised disease are offered radical treatments such as surgery or radiotherapy, which can result in severe side effects.
Freddie C Hamdy   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy